NEDD9 and acute myeloid leukemia: In addition, since minimal residual disease (MRD) status has been pointed out in recent studies as a strong prognostic factor for relapse and DFS in AML, it would be interesting to analyze the correlation between NEDD9 expression and MRD status in the future.